Substance Use Disorder Assessment (Formerly Substance Abuse Assessment)
- Changes in Mood
- Poor Hygiene
- Odd Sleep Patterns
- Frequent Injuries
- Relationship or Job Difficulty
- Poor Performance
- Anorexia OR Weight Loss
- Social Isolation
- Financial Problems
Alcohol Use Disorder Assessment (Formerly Alcohol Abuse Assessment)
- CNS Depression
- Wernicke-Korsakoff Syndrome
- GI Distress
- Cardiomyopathy
- Pancreatitis
- Cirrhosis
- Immunosuppression
- Sexual Dysfunction
- Screening (Assessments)
Alcohol Use Disorder Interventions (Formerly Alcohol Abuse Interventions)
- Reduce Environmental Stimuli
- Antianxiety Medications
- Vitamin Supplements
- Seizure Precautions
- Suicide Precautions
- Fever
- Identify Support Systems
- Group Therapy
- Disulfiram
- Naltrexone
Opioid Use Disorder and Withdrawal Assessment (Formerly Opioid Abuse and Withdrawal Assessment)
- Euphoria
- Miosis
- CNS Depression
- Yawning
- Gooseflesh
- Sweating
- Rhinorrhea
- Kicking Movements
- Naloxone
Amphetamines Intoxication Assessment
- Euphoria
- Insomnia
- Mydriasis
- Diaphoresis
- Hypertension
- Tachycardia
- Paranoia
- Anxiety
- Anorexia
- Seizures
Marijuana Intoxication Assessment
- Euphoria
- Slowed Reaction Time
- Conjunctival Injection
- Increased Appetite
- Anxiety
- Social Withdrawal
- Paranoid Delusions
Benzodiazepine Intoxication Assessment
- Drowsiness
- Confusion
- Respiratory Depression
- Hypotension
- Coma
- Flumazenil (Romazicon)
Cocaine Intoxication Assessment
- Euphoria
- Delusions
- Mydriasis
- Hallucinations
- Agitation
- Hypertension
- Arrhythmias
- Hyperthermia
- Seizures
- Nasal Septum Perforation
LSD Intoxication Assessment
- Psychosis
- Perceptual Distortion
- Visual Hallucinations
- Paranoia
- Depersonalization
- Anxiety
- Tachycardia
- Flashbacks
Phencyclidine (PCP) Intoxication Assessment
- Violent Behavior
- Motor Issues
- Nystagmus
- Increased Pain Tolerance
- Tachycardia
- Delirium
- Seizures
- Psychosis
MDMA (Ecstasy) Toxicity: Management
- Airway Management
- Management of Hypertension
- Benzodiazapines
- Nitroprusside
- Activated Charcoal if Within One Hour of Ingestion
- Ice Bath if Hyperthermic
- Cyproheptadine if Serotonin Syndrome
- Fluid Restriction for Hyponatremia
- Hypertonic Saline if Hyponatremia + Altered Mental Status
MDMA (Ecstasy) Toxicity: Mechanism and Clinical Findings
- Sympathomimetic
- Increases Release and Blocks Reuptake of Catecholamines
- Euphoria
- Increased Alertness
- Extreme Hyponatremia Leading to Altered Mental Status
- Acute Liver Injury
- Serotonin Syndrome
- Rhabdomyolysis
- Hypertensive Urgency/Emergency
- Arrhythmia
Buprenorphine-Naloxone (Suboxone)
- Combination Drug
- Partial Opioid Receptor Agonist (Buprenorphine)
- Opioid Receptor Antagonist (Naloxone)
- Opioid Use Disorder
- CNS Depression
- Diaphoresis
- Hypotension
- Low Abuse Potential
Substance Use Disorder
- 2 or More Symptoms For 1 year
- Tolerance
- Withdrawal Symptoms
- Cravings
- Using More Than Intended
- Inability to Cut Down
- Time-Consuming Substance Acquisition
- Impaired Functioning at Work
- Reduced Recreational Activities
- Dangerous Activities
- Continued Use
Neonatal Abstinence Syndrome
- Maternal Substance Abuse
- Withdrawal Symptoms in Neonate
- Diarrhea
- Irritability
- Sneezing
- Tremor
- Increased Moro Reflex
- Tachypnea
- Maternal Screening
- Nonpharmacologic Therapy
- Opioids
Fetal Alcohol Syndrome Characteristics and Clinical Features
- Teratogenic Disease
- Intellectual Disability
- Midline Craniofacial Abnormalities
- Holoprosencephaly
- Thin Upper Lip
- Smooth Philtrum
- Short Palpebral Fissures
- Cardiopulmonary Abnormalities
- Musculoskeletal Abnormalities
- Genitourinary Abnormalities